239 related articles for article (PubMed ID: 8784202)
1. Role of the P2 residue in determining the specificity of serpins.
Djie MZ; Le Bonniec BF; Hopkins PC; Hipler K; Stone SR
Biochemistry; 1996 Sep; 35(35):11461-9. PubMed ID: 8784202
[TBL] [Abstract][Full Text] [Related]
2. Role of Leu99 of thrombin in determining the P2 specificity of serpins.
Rezaie AR
Biochemistry; 1997 Jun; 36(24):7437-46. PubMed ID: 9200692
[TBL] [Abstract][Full Text] [Related]
3. Role of the P6-P3' region of the serpin reactive loop in the formation and breakdown of the inhibitory complex.
Plotnick MI; Schechter NM; Wang ZM; Liu X; Rubin H
Biochemistry; 1997 Nov; 36(47):14601-8. PubMed ID: 9398179
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory mechanism of serpins. Identification of steps involving the active-site serine residue of the protease.
Stone SR; Le Bonniec BF
J Mol Biol; 1997 Jan; 265(3):344-62. PubMed ID: 9018048
[TBL] [Abstract][Full Text] [Related]
5. Distortion of the active site of chymotrypsin complexed with a serpin.
Plotnick MI; Mayne L; Schechter NM; Rubin H
Biochemistry; 1996 Jun; 35(23):7586-90. PubMed ID: 8652540
[TBL] [Abstract][Full Text] [Related]
6. The antithrombin P1 residue is important for target proteinase specificity but not for heparin activation of the serpin. Characterization of P1 antithrombin variants with altered proteinase specificity but normal heparin activation.
Chuang YJ; Swanson R; Raja SM; Bock SC; Olson ST
Biochemistry; 2001 Jun; 40(22):6670-9. PubMed ID: 11380262
[TBL] [Abstract][Full Text] [Related]
7. Full or partial substitution of the reactive center loop of alpha-1-proteinase inhibitor by that of heparin cofactor II: P1 Arg is required for maximal thrombin inhibition.
Filion ML; Bhakta V; Nguyen LH; Liaw PS; Sheffield WP
Biochemistry; 2004 Nov; 43(46):14864-72. PubMed ID: 15544357
[TBL] [Abstract][Full Text] [Related]
8. The inhibitory specificity of human proteinase inhibitor 8 is expanded through the use of multiple reactive site residues.
Dahlen JR; Foster DC; Kisiel W
Biochem Biophys Res Commun; 1998 Mar; 244(1):172-7. PubMed ID: 9514892
[TBL] [Abstract][Full Text] [Related]
9. Development of a novel recombinant serpin with potential antithrombotic properties.
Hopkins PC; Crowther DC; Carrell RW; Stone SR
J Biol Chem; 1995 May; 270(20):11866-71. PubMed ID: 7744836
[TBL] [Abstract][Full Text] [Related]
10. Evolution of serpin specificity: cooperative interactions in the reactive-site loop sequence of antithrombin specifically restrict the inhibition of activated protein C.
Hopkins PC; Pike RN; Stone SR
J Mol Evol; 2000 Nov; 51(5):507-15. PubMed ID: 11080374
[TBL] [Abstract][Full Text] [Related]
11. The role of the insertion loop around tryptophan 148 in tthe activity of thrombin.
DiBella EE; Scheraga HA
Biochemistry; 1996 Apr; 35(14):4427-33. PubMed ID: 8605192
[TBL] [Abstract][Full Text] [Related]
12. Engineering an anion-binding cavity in antichymotrypsin modulates the "spring-loaded" serpin-protease interaction.
Lukacs CM; Rubin H; Christianson DW
Biochemistry; 1998 Mar; 37(10):3297-304. PubMed ID: 9521649
[TBL] [Abstract][Full Text] [Related]
13. Modeling of serpin-protease complexes: antithrombin-thrombin, alpha 1-antitrypsin (358Met-->Arg)-thrombin, alpha 1-antitrypsin (358Met-->Arg)-trypsin, and antitrypsin-elastase.
Whisstock J; Lesk AM; Carrell R
Proteins; 1996 Nov; 26(3):288-303. PubMed ID: 8953650
[TBL] [Abstract][Full Text] [Related]
14. The effects of reactive site location on the inhibitory properties of the serpin alpha(1)-antichymotrypsin.
Plotnick MI; Rubin H; Schechter NM
J Biol Chem; 2002 Aug; 277(33):29927-35. PubMed ID: 12055188
[TBL] [Abstract][Full Text] [Related]
15. Molecular basis of residue 192 participation in determination of coagulation protease specificity.
Rezaie AR; Esmon CT
Eur J Biochem; 1996 Dec; 242(3):477-84. PubMed ID: 9022671
[TBL] [Abstract][Full Text] [Related]
16. Identification of thrombin residues that modulate its interactions with antithrombin III and alpha 1-antitrypsin.
Le Bonniec BF; Guinto ER; Stone SR
Biochemistry; 1995 Sep; 34(38):12241-8. PubMed ID: 7547966
[TBL] [Abstract][Full Text] [Related]
17. Investigating serpin-enzyme complex formation and stability via single and multiple residue reactive centre loop substitutions in heparin cofactor II.
Sutherland JS; Bhakta V; Sheffield WP
Thromb Res; 2006; 117(4):447-61. PubMed ID: 15869786
[TBL] [Abstract][Full Text] [Related]
18. Pigment epithelium-derived factor behaves like a noninhibitory serpin. Neurotrophic activity does not require the serpin reactive loop.
Becerra SP; Sagasti A; Spinella P; Notario V
J Biol Chem; 1995 Oct; 270(43):25992-9. PubMed ID: 7592790
[TBL] [Abstract][Full Text] [Related]
19. A unique serpin P1' glutamate and a conserved β-sheet C arginine are key residues for activity, protease recognition and stability of serpinA12 (vaspin).
Ulbricht D; Pippel J; Schultz S; Meier R; Sträter N; Heiker JT
Biochem J; 2015 Sep; 470(3):357-67. PubMed ID: 26199422
[TBL] [Abstract][Full Text] [Related]
20. Contributions of basic amino acids in the autolysis loop of factor XIa to serpin specificity.
Rezaie AR; Sun MF; Gailani D
Biochemistry; 2006 Aug; 45(31):9427-33. PubMed ID: 16878977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
